DAVID KON: Open Payments
NPI 1407040454 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,336 in 155 payments from 21 companies in 2025. Trend: 2023 $2,821 · 2024 $3,016 · 2025 $3,336
Food & beverage: $3,271Education: $65
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 36 | $739 |
| ABBVIE INC. | 26 | $477 |
| Galderma Laboratories, L.P. | 12 | $338 |
| Incyte Corporation | 12 | $291 |
| Janssen Biotech, Inc. | 11 | $288 |
| PFIZER INC. | 8 | $175 |
| GENZYME CORPORATION | 9 | $168 |
| Organon LLC | 10 | $156 |
| Novartis Pharmaceuticals Corporation | 5 | $134 |
| Regeneron Healthcare Solutions, Inc. | 4 | $117 |
Products named: ADBRY, NEMLUVIO, SKYRIZI, OPZELURA, ANZUPGO, TREMFYA, DUPIXENT, CIBINQO.
Industry payments across VA — which companies pay providers there.
